CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an analysis of HIMS stock now.

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...